Tag Archive for: congenital hyperinsulinism

The treatment, ersodetug, is currently being tested on participants with congenital hyperinsulinism, a genetic disorder that causes low blood sugar.

Zealand Pharma said on Saturday that the U.S. Food and Drug Administration (FDA) had declined to approve its drug for preventing and treating low blood sugar in children with a genetic disorder after finding deficiencies at a third-party manufacturing facility.